"Aaron F. Barkoff submits: In a 2-1 decision released yesterday, the Federal Circuit affirmed a 2004 district court decision finding AstraZeneca's (AZN) U.S. Patent No. 6,013,281 invalid as inherently anticipated. The '281 patent covers a process for making Prilosec, Astra's blockbuster anti-ulcer medication."
4.24.2007
Court Affirms Invalidity of AstraZeneca Prilosec Process Patent - Seeking Alpha
